COLONY GROUP LLC - ARIAD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
COLONY GROUP LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$4,000
+100.0%
500
+105.8%
0.00%
Q4 2014$2,000
+100.0%
2430.0%0.00%
Q3 2014$1,000
-97.0%
243
-95.4%
0.00%
-100.0%
Q2 2014$33,000
-21.4%
5,2430.0%0.00%
-33.3%
Q1 2014$42,000
+16.7%
5,2430.0%0.01%
+20.0%
Q4 2013$36,0005,2430.01%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$175,916,00040.51%
Consonance Capital Management LP 8,695,742$119,045,00011.46%
Tamarack Advisers, LP 3,700,000$49,358,0007.76%
Opaleye Management Inc. 1,045,000$14,306,0007.49%
Granite Point Capital Management, L.P. 457,415$6,262,0002.44%
Redmile Group, LLC 2,138,471$29,276,0002.33%
IRONWOOD INVESTMENT MANAGEMENT LLC 206,010$2,820,0002.17%
Palo Alto Investors LP 2,587,617$35,424,0002.06%
PRICE MICHAEL F 940,000$12,869,0001.71%
HighVista Strategies LLC 638,086$8,735,0001.62%
View complete list of ARIAD PHARMACEUTICALS INC shareholders